Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 6
2022 19
2023 21
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
The global burden of metabolic disease: Data from 2000 to 2019.
Chew NWS, Ng CH, Tan DJH, Kong G, Lin C, Chin YH, Lim WH, Huang DQ, Quek J, Fu CE, Xiao J, Syn N, Foo R, Khoo CM, Wang JW, Dimitriadis GK, Young DY, Siddiqui MS, Lam CSP, Wang Y, Figtree GA, Chan MY, Cummings DE, Noureddin M, Wong VW, Ma RCW, Mantzoros CS, Sanyal A, Muthiah MD. Chew NWS, et al. Among authors: kong g. Cell Metab. 2023 Mar 7;35(3):414-428.e3. doi: 10.1016/j.cmet.2023.02.003. Cell Metab. 2023. PMID: 36889281 Free article.
Efficacy and safety of tirzepatide for treatment of overweight or obesity. A systematic review and meta-analysis.
Tan B, Pan XH, Chew HSJ, Goh RSJ, Lin C, Anand VV, Lee ECZ, Chan KE, Kong G, Ong CEY, Chung HC, Young DY, Chan MY, Khoo CM, Mehta A, Muthiah MD, Noureddin M, Ng CH, Chew NWS, Chin YH. Tan B, et al. Among authors: kong g. Int J Obes (Lond). 2023 Aug;47(8):677-685. doi: 10.1038/s41366-023-01321-5. Epub 2023 May 31. Int J Obes (Lond). 2023. PMID: 37253796 Review.
The global syndemic of metabolic diseases in the young adult population: A consortium of trends and projections from the Global Burden of Disease 2000-2019.
Chong B, Kong G, Shankar K, Chew HSJ, Lin C, Goh R, Chin YH, Tan DJH, Chan KE, Lim WH, Syn N, Chan SP, Wang JW, Khoo CM, Dimitriadis GK, Wijarnpreecha K, Sanyal A, Noureddin M, Siddiqui MS, Foo R, Mehta A, Figtree GA, Hausenloy DJ, Chan MY, Ng CH, Muthiah M, Mamas MA, Chew NWS. Chong B, et al. Among authors: kong g. Metabolism. 2023 Apr;141:155402. doi: 10.1016/j.metabol.2023.155402. Epub 2023 Jan 28. Metabolism. 2023. PMID: 36717058
Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the Global Burden of Disease Study 2019.
Chong B, Jayabaskaran J, Kong G, Chan YH, Chin YH, Goh R, Kannan S, Ng CH, Loong S, Kueh MTW, Lin C, Anand VV, Lee ECZ, Chew HSJ, Tan DJH, Chan KE, Wang JW, Muthiah M, Dimitriadis GK, Hausenloy DJ, Mehta AJ, Foo R, Lip G, Chan MY, Mamas MA, le Roux CW, Chew NWS. Chong B, et al. Among authors: kong g. EClinicalMedicine. 2023 Feb 16;57:101850. doi: 10.1016/j.eclinm.2023.101850. eCollection 2023 Mar. EClinicalMedicine. 2023. PMID: 36864983 Free PMC article.
Epicardial Adipose Tissue Assessed by Computed Tomography and Echocardiography Are Associated With Adverse Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.
Chong B, Jayabaskaran J, Ruban J, Goh R, Chin YH, Kong G, Ng CH, Lin C, Loong S, Muthiah MD, Khoo CM, Shariff E, Chan MY, Lajeunesse-Trempe F, Tchernof A, Chevli P, Mehta A, Mamas MA, Dimitriadis GK, Chew NWS. Chong B, et al. Among authors: kong g. Circ Cardiovasc Imaging. 2023 May;16(5):e015159. doi: 10.1161/CIRCIMAGING.122.015159. Epub 2023 May 16. Circ Cardiovasc Imaging. 2023. PMID: 37192298
Efficacy and safety of tirzepatide, GLP-1 receptor agonists, and other weight loss drugs in overweight and obesity: a network meta-analysis.
Pan XH, Tan B, Chin YH, Lee ECZ, Kong G, Chong B, Kueh M, Khoo CM, Mehta A, Majety P, Grandhi GR, Dimitriadis GK, Foo R, Chew NWS, Le Roux CW, Mamas MA, Chan MY. Pan XH, et al. Among authors: kong g. Obesity (Silver Spring). 2024 May;32(5):840-856. doi: 10.1002/oby.24002. Epub 2024 Feb 27. Obesity (Silver Spring). 2024. PMID: 38413012 Review.
The prognostic value of including non-alcoholic fatty liver disease in the definition of metabolic syndrome.
Fu CE, Yong JN, Ng CH, Nah B, Chew NWS, Chin YH, Kong G, Tan DJH, Lim WH, Lim LKE, Zeng RW, Shabbir A, Tan EXX, Huang DQ, Khoo CM, Siddqui MS, Chan MYY, Noureddin M, Mamas MA, Muthiah M. Fu CE, et al. Among authors: kong g. Aliment Pharmacol Ther. 2023 May;57(9):979-987. doi: 10.1111/apt.17397. Epub 2023 Jan 29. Aliment Pharmacol Ther. 2023. PMID: 36710531
Trends and predictions of metabolic risk factors for acute myocardial infarction: findings from a multiethnic nationwide cohort.
Chew NWS, Chong B, Kuo SM, Jayabaskaran J, Cai M, Zheng H, Goh R, Kong G, Chin YH, Imran SS, Liang M, Lim P, Yong TH, Liew BW, Chia PL, Ho HH, Foo D, Khoo D, Huang Z, Chua T, Tan JWC, Yeo KK, Hausenloy D, Sim HW, Kua J, Chan KH, Loh PH, Lim TW, Low AF, Chai P, Lee CH, Yeo TC, Yip J, Tan HC, Mamas MA, Nicholls SJ, Chan MY. Chew NWS, et al. Among authors: kong g. Lancet Reg Health West Pac. 2023 May 31;37:100803. doi: 10.1016/j.lanwpc.2023.100803. eCollection 2023 Aug. Lancet Reg Health West Pac. 2023. PMID: 37693863 Free PMC article.
42 results